M’Sure-S
Sirolimus Eluting Coronary Stent

M’Sure –S uses a validated formulation of low dose Sirolimus (1.30µg/mm ) timed to elute in ̴30 days to 45 days from a biodegradable & biocompatible polymer base (PLLA & PLGA) which degrades simultaneously.

Features:

  • M’Sure-S stent is built on 59µm cobalt chromium platform
  • Our special electro-polishing technique ensures an ultra-low strut thickness of 59µm
  • M’Sure-S Ensure 0.29% foreshortening & <3% recoil
  • Provide optimal radial strength, high degree of flexibility & excellent Scaffolding
  • Sirolimus is an ideal choice considering that it acts on the common final pathway of cell division cycle without exceptional risk of necrosis induction
  • M’Sure-S has 1.30µg/mm2 of Sirolimus loading on stent, eluted within 30 days
  • Biodegradable and biocompatible co-polymer formulation
  • Poly-L-Lactic acid ( PLLA) & poly lactic-co-glycolic acid (PLGA)
  • 2 µm of drug & polymer coating